{"id":12084,"date":"2025-03-13T22:41:00","date_gmt":"2025-03-13T21:41:00","guid":{"rendered":"https:\/\/valintermed.com\/?p=12084"},"modified":"2025-03-13T22:41:00","modified_gmt":"2025-03-13T21:41:00","slug":"mitohondrialnaya-neyrogastrointestinalnaya-entsefalopatiya","status":"publish","type":"post","link":"https:\/\/valintermed.com\/en\/medlibrary\/mitohondrial-neurogastrointestinal-tract-entefalopathy\/","title":{"rendered":"Mitochondrial neurogastrointestinal encephalopathy"},"content":{"rendered":"
<\/div>\n

Mitochondrial neurogastrointestinal encephalopathy (MNGE) is a rare hereditary disease characterized by mitochondrial dysfunction, which leads to multiple organ and system disorders, including the central nervous system, gastrointestinal tract, and others. This condition causes a wide range of clinical manifestations, ranging from neurological manifestations such as epilepsy to gastrointestinal disorders, including chronic diarrhea and dyspepsia. MNGE is associated with insufficient energy production at the cellular level, which ultimately affects the functioning of organs sensitive to metabolic disorders. Today, doctors encounter this pathology in patients of all ages, including children and adults, which requires a comprehensive approach to diagnosis and treatment.<\/p>\n

\n
\n

Content<\/p>\nToggle<\/span><\/path><\/svg><\/svg><\/span><\/span><\/span><\/a><\/span><\/div>\n